ADVERTISEMENT

Transitions Magazine

Transitions is published bi-monthly for members of the APhA New Practitioner Network. The online newsletter contains information focused on life inside and outside pharmacy practice, providing guidance on various areas of professional, personal, and practice development. Each issue includes in-depth articles on such topics as personal financial management, innovative practice sites, career profiles, career development tools, residency and postgraduate programs, and more.

Dexamethasone appears safe in preventing postsurgery nausea Dexamethasone appears safe in preventing postsurgery nausea

Dexamethasone appears safe in preventing postsurgery nausea

0 20046
Although dexamethasone is often used to prevent nausea and vomiting after surgery, concerns have been raised that it may increase the risk of surgical-site infection. A new study from researchers in New Zealand and Australia published on May 6 in the New England Journal of Medicine showed that dexamethasone was noninferior to placebo in the incidence of surgical-site infection within 30 days after nonurgent, noncardiac surgery.  
Do adolescents have better HPV vaccination rates than young adults? Do adolescents have better HPV vaccination rates than young adults?

Do adolescents have better HPV vaccination rates than young adults?

0 19507
Researchers from the University of Michigan examined vaccination against human papillomavirus (HPV) in young adults versus adolescents for an 8-year period, from 2010 to 2018. Regardless of what age they were at first dose, more survey respondents opted for vaccination as the years passed. Still, compared with adolescents—68% of whom...
ISMP updates COVID-19 vaccine errors ISMP updates COVID-19 vaccine errors

ISMP updates COVID-19 vaccine errors

The Institute for Safe Medication Practices (ISMP) continues to track the errors that have been reported from the currently authorized COVID-19...
0 21729
FDA approves higher dosage of naloxone nasal spray FDA approves higher dosage of naloxone nasal spray

FDA approves higher dosage of naloxone nasal spray

On April 30, FDA announced the approval of a higher dosage of naloxone hydrochloride nasal spray (Kloxxado—Hikma Pharmaceuticals) to treat...
0 21540
CDC recommends pregnant women get COVID-19 vaccine CDC recommends pregnant women get COVID-19 vaccine

CDC recommends pregnant women get COVID-19 vaccine

Pregnant women should get the COVID-19 vaccine, said CDC. CDC Director Rochelle Walensky, MD, noted at a White House briefing that vaccination...
0 20813
STDs reach all time high STDs reach all time high

STDs reach all time high

Annual cases of sexually transmitted diseases (STDs) in the United States continued to increase in 2019, hitting an all-time high for the sixth...
0 19907
CDC: Overdose deaths surged during pandemic CDC: Overdose deaths surged during pandemic

CDC: Overdose deaths surged during pandemic

More than 87,000 Americans died from drug overdoses in the 12-month period that ended in September 2020, according to preliminary CDC data, which...
0 21676
How to talk to patients about the J&J vaccine How to talk to patients about the J&J vaccine

How to talk to patients about the J&J vaccine

Patients will be coming to pharmacists with questions and concerns as the recommendation to suspend use of the Janssen (Johnson & Johnson,...
0 21174

FDA issues EUA for bamlanivimab to treat COVID-19

On November 10, FDA issued an emergency use authorization (EUA) to Eli Lilly for the investigational monoclonal antibody therapy bamlanivimab to treat mild to moderate COVID-19 in adult and pediatric patients.

First242526272829303133
Advertisement
Advertisement
Advertisement
Advertisement

ADVERTISEMENT